Filing Flows › Comparisons › BSAA vs CVSA
Best SPAC I Acquisition vs Covista: BSAA and CVSA compared
Best SPAC I Acquisition is the larger company: $1.2B of revenue in its latest quarter (Q1 2026) against $512M for Covista (Q1 FY27). Covista is more profitable, with an operating margin of 19.2% against 0.0%.
Where the money goes: BSAA and CVSA
Best SPAC I Acquisition (BSAA) · Q1 2026
Best SPAC I Acquisition, Q1 2026: revenue $1.2B, operating margin 0.0%, net earnings $359K, operating cash flow −$123K. The chart follows the revenue to costs, profit and cash.
Covista (CVSA) · Q1 FY27
Covista, Q1 FY27: revenue $512M (+11% year over year), operating margin 19.2%, net earnings $67.4M, operating cash flow $114M. The chart follows the revenue to costs, profit and cash.
| Best SPAC I Acquisition (BSAA) | Covista (CVSA) | |
|---|---|---|
| Latest quarter | Q1 2026 | Q1 FY27 |
| Revenue | $1.2B | $512M |
| Revenue growth, Y/Y | — | +11% |
| Operating margin | 0.0% | 19.2% |
| Net earnings | $359K | $67.4M |
| Net margin | 0.0% | 13.2% |
| Operating cash flow | −$123K | $114M |
| Free cash flow | — | $76.4M |
| Market value | $22.0M | $3.8B |
| P/E | 18.0× | 15.1× |
| Analysts’ mean target | — | $159.00 |
Where the revenue comes from
Covista
- Walden: $217M (42%)
- Chamberlain: $192M (38%)
- Medical and Veterinary: $102M (20%)
Questions
Which is bigger, Best SPAC I Acquisition or Covista?
Best SPAC I Acquisition is the larger company: $1.2B of revenue in its latest quarter (Q1 2026) against $512M for Covista (Q1 FY27).
Is Best SPAC I Acquisition or Covista growing faster?
Covista is more profitable, with an operating margin of 19.2% against 0.0%.
More: Best SPAC I Acquisition earnings · how Best SPAC I Acquisition makes money · Covista earnings · how Covista makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Apr 28, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.